Quantbot Technologies’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$467K Buy
75,780
+49,741
+191% +$413K 0.02% 883
2025
Q4
$271K Sell
26,039
-120,209
-82% -$1.21M 0.01% 1145
2025
Q3
$1.31M Buy
146,248
+91,815
+169% +$806K 0.04% 680
2025
Q2
$708K Sell
54,433
-32,760
-38% -$493K 0.02% 894
2025
Q1
$2.2M Buy
87,193
+53,749
+161% +$1.6M 0.07% 413
2024
Q4
$1.15M Buy
33,444
+8,041
+32% +$363K 0.04% 581
2024
Q3
$1.26M Sell
25,403
-10,594
-29% -$543K 0.05% 544
2024
Q2
$2.17M Sell
35,997
-17,689
-33% -$1.01M 0.1% 306
2024
Q1
$2.77M Buy
53,686
+4,167
+8% +$205K 0.16% 175
2023
Q4
$2M Buy
49,519
+48,621
+5,414% +$1.43M 0.12% 272
2023
Q3
$25K Sell
898
-19,338
-96% -$577K ﹤0.01% 1328
2023
Q2
$583K Buy
20,236
+14,044
+227% +$312K 0.04% 617
2023
Q1
$103K Buy
+6,192
New +$87.4K 0.01% 1078

Other funds holding RXST

Quantbot Technologies's RXST Position: Q1 2026 in Review

Quantbot Technologies increased its RxSight (RXST) stake by 191% in Q1 2026, buying an estimated $413K and bringing the position to 75,780 shares worth $467K. The position accounts for 0.02% of the portfolio, ranked #883.

Quantbot Technologies first reported a position in RXST in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.77M in Q1 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Quantbot Technologies held 75,780 shares of RxSight worth $467K as of Q1 2026.
  • Quantbot Technologies bought 49,741 RxSight shares in Q1 2026, an estimated $413K.
  • RxSight made up 0.02% of Quantbot Technologies's portfolio in Q1 2026, its #883 holding.
  • Quantbot Technologies first reported a position in RxSight in Q1 2023 and has held it in 13 quarters since.
  • Quantbot Technologies's RxSight position peaked at $2.77M in Q1 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.